MyFinsight
Home
Blog
About
Maturities of investments
$12,250K
Proceeds from issuance of
term loan
$10,000K
Proceeds from sale of
property and equipment
$44K
Proceeds from exercise of
stock options under...
$73K
Proceeds from issuance of
common stock under...
$31K
Proceeds from exercise of
pre-funded warrants
$3K
Net cash (used in)
provided by investing...
$6,523K
Net cash provided by
(used in) financing...
$137K
Canceled cashflow
$5,771K
Canceled cashflow
$9,970K
Net increase in
cash, cash...
-$9,397K
Canceled cashflow
$6,660K
Stock-based compensation
$2,683K
Accrued expenses and
other current...
$1,360K
Loss on early debt
extinguishment
-$904K
Non-cash lease costs
$349K
Loss on disposal of
fixed assets
-$246K
Prepaid expenses and
other current assets
-$232K
Depreciation and
amortization
$86K
Accretion of term loan
discount and issuance...
$66K
Other assets
-$1K
Purchase of investments
$5,754K
Purchase of property and
equipment
$17K
Payments for early debt
extinguishment
$8,176K
Principal payments on term
loan
$1,304K
Principal payments on
finance leases
$236K
Payments of issuance
costs related to...
$150K
Payments of debt issuance
costs
$104K
Net cash used in
operating activities
-$16,057K
Canceled cashflow
$5,927K
Interest income
$1,508K
Net loss
-$17,971K
Canceled cashflow
$1,508K
Gain on lease
termination
$2,592K
Accounts payable
-$765K
Net accretion of
discounts on investments
$341K
Other non-current
liabilities
-$315K
something is missing
$13,606K
Total lease
termination (gain) and...
$238K
Loss from operations
-$18,033K
Canceled cashflow
$13,844K
Loss on debt
extinguishment
-$904K
Interest expense
$285K
Other expense, net
-$257K
Total research and
development expenses
$26,744K
Total general and
administrative expenses
$5,133K
Back
Back
Cash Flow
ALX ONCOLOGY HOLDINGS INC (ALXO)
ALX ONCOLOGY HOLDINGS INC (ALXO)
source: myfinsight.com